ARCTIC: Additional proof against antiplatelet adjusted therapy

This publication has 11 references indexed in Scilit:

• Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
  International Journal of Cardiology, 2013
• A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
  JACC, 2012
• Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention
  JACC, 2011
• Error in a Study of the Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Artery Stent Implantation
  JAMA, 2011
• Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
  American Heart Journal, 2011
• Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
  JAMA, 2010
• Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention
  Circulation, 2009
• Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders
  JACC: Cardiovascular Interventions, 2008
• Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
  JACC, 2007
• Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
  New England Journal of Medicine, 2006